Interventional device developer Boston Scientific plans to explore the sale of its cardiac surgery and vascular surgery businesses, the Natick, MA-based firm reported. The move is part of the company's plan to streamline its portfolio and strengthen its operating and financial performance.
Boston Scientific acquired the cardiac surgery business in April of last year as part of its deal with Guidant. The business develops medical technologies to provide less-invasive therapies in cardiac surgery.
Its vascular surgery business was acquired in 1995 as part of its purchase of Meadox Medicals; it develops synthetic grafts and patches for the repair of abdominal aortic aneurysms and peripheral vascular anatomy.
By AuntMinnie.com staff writers
August 16, 2007
Related Reading
Boston Scientific to keep Endosurgery unit, August 3, 2007
Boston Scientific begins Taxus Element stent trial, July 20, 2007
Boston Scientific brings Taxus Express² to Japan, May 8, 2007
Boston Scientific gets Japanese nod for Taxus, April 3, 2007
Boston Scientific shows year-end, Q4 sales growth, February 1, 2007
Copyright © 2007 AuntMinnie.com
